Atrium Therapeutics, Inc. - Common Stock (NQ:RNA)

8.350 +0.030 (+0.36%)

Delayed Quote Updated: 1:34 PM EDT, Oct 28, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Atrium Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

EXCLUSIVE: The Benzinga Moneymaker Series, 5 Emerging Stocks For Investors To Watch ↗

December 15, 2022

Investors are on the hunt for undervalued, underfollowed and emerging stocks to spot opportunities. The rise of social media and retail traders gave way to countless methods to uncover new information....

Via Benzinga

Novavax, Tesla, Western Digital And Some Other Big Stocks Moving Lower In Today's Pre-Market Session ↗

December 15, 2022

U.S. stock futures traded lower this morning. Here are some big stocks recording losses in today’s pre-market trading session.

Via Benzinga

Tesla, Amazon, Novavax, Lennar Corp, Avidity Biosciences: Why These 5 Stocks Are Drawing Retail Investors' Attention Today ↗

December 14, 2022

Major Wall Street indices closed in the red on Wednesday despite an anticipated 50 basis points hike by the Federal Reserve as Chair Jerome Powell indicated the need for more data before the central...

Via Benzinga

Expert Ratings for Avidity Biosciences ↗

December 14, 2022

Via Benzinga

Dow Drops Over 300 Points After Fed Raises Key Overnight Interest Rate By 50 bps ↗

December 14, 2022

U.S. stocks turned lower toward the end of trading, after the Federal Reserve announced its policy decision.

Via Benzinga

Recap: Avidity Biosciences Q2 Earnings ↗

August 09, 2022

Avidity Biosciences (NASDAQ:RNA) reported its Q2 earnings results on Tuesday, August 9, 2022 at 04:00 PM. Here's what investors need to know about the announcement.

Via Benzinga

Why Netcapital Shares Are Trading Lower By Over 33%? Here Are 50 Stocks Moving In Wednesday's Mid-Day Session ↗

December 14, 2022

Gainers Crown ElectroKinetics Corp. (NASDAQ: CRKN) shares rose 153% to $0.3325 after gaining 14% on Tuesday. Crown ElectroKinetics, last month, posted a Q3 loss of $0.18 per share.

Via Benzinga

These Biotech Stocks Are the Nasdaq's Big Wednesday Winners ↗

December 14, 2022

Business wins are shining the spotlight on these two companies.

Via The Motley Fool

Avidity Biosciences (NASDAQ: RNA) Posts Positive Phase 1/2 MARINA Data on AOC 1001, Announcing the First Successful Delivery of RNA to Muscle

December 14, 2022

Avidity Biosciences, Inc. (NASDAQ: RNA) is engaged as a biopharmaceutical company, which is focused on developing a new class of

Via Spotlight Growth

How A First-Ever In Gene Silencing Catapulted Avidity Biosciences Into The Stratosphere ↗

December 14, 2022

The company tested its efforts in myotonic dystrophy 1, a form of muscular dystrophy.

Via Investor's Business Daily

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

December 14, 2022

Via Benzinga

Avidity Biosciences Shares Gain On Encouraging Data From Early-Stage Myotonic Dystrophy Trial ↗

December 14, 2022

Via Benzinga

REV Group, Avidity Biosciences And Some Other Big Stocks Moving Higher On Wednesday ↗

December 14, 2022

U.S. stocks traded higher, with the Dow Jones gaining over 100 points on Wednesday. Here are some big stocks recording gains in today’s session.

Via Benzinga

What's Going On With Avidity Biosciences Stock? ↗

December 14, 2022

Avidity Biosciences Inc (NASDAQ: RNA) shares are trading higher Wednesday after the company announced positive data demonstrating the first-ever successful

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

December 14, 2022

Via Benzinga

AiViva's Diverse Product Pipeline Could Have The Potential To Transform Unmet Medical Needs ↗

November 21, 2022

AiViva BioPharma is a clinical-stage biotech company developing innovative and transformative treatments and products to address unmet medical needs for a wide array of diseases.

Via Benzinga

Short Interest Sector Focus: Healthcare Sector ↗

October 20, 2022

As of the close of business on Wednesday, 10/19, we captured the Top 10 Highest Short Interest % stocks within the Healthcare Sector. The average short interest for stocks within the Healthcare sector...

Via Benzinga

Nasdaq Turns Higher; Crude Oil Rises Over 2% ↗

September 27, 2022

U.S. stocks pared some losses toward the end of trading, with the Nasdaq Composite turning higher on Tuesday.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

September 27, 2022

Gainers

Via Benzinga

Why NLS Pharmaceutics Shares Dipped Over 23%; Here Are 67 Biggest Movers From Yesterday ↗

September 28, 2022

Gainers

Via Benzinga

Avidity Biosciences, Kronos Worldwide And Some Other Big Stocks Moving Lower On Tuesday ↗

September 27, 2022

U.S. stocks traded lower, with the Dow Jones dropping around 180 points on Tuesday. Here are some big stocks recording losses in today’s session.

Via Benzinga

US Stocks Turn Lower; Dow Dips 175 Points ↗

September 27, 2022

U.S. stocks turned lower midway through trading, with the Dow Jones dropping around 175 points on Tuesday.

Via Benzinga

Why Bellerophon Therapeutics Shares Are Trading Higher By 24%, Here Are 44 Stocks Moving In Tuesday's Mid-Day Session ↗

September 27, 2022

Gainers

Via Benzinga

US Stocks Open Higher; Dow Surges 300 Points ↗

September 27, 2022

U.S. stocks traded higher this morning, with the Dow Jones gaining around 300 points on Tuesday.

Via Benzinga

Highly Rated Avidity Biosciences Hammered After Side Effect Sidelines Study ↗

September 27, 2022

The stock has a high IBD Digital rating, but plummeted on the news.

Via Investor's Business Daily

FDA Slaps Clinical Hold On Avidity's Early-Stage Myotonic Dystrophy Trial ↗

September 27, 2022

The FDA has placed a partial clinical hold on new participant enrollment in Avidity Biosciences Inc's (NASDAQ: RNA) Phase 1/2 MARINA trial of AOC 1001 in adults with myotonic dystrophy type 1 (DM1).

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

September 27, 2022

Gainers 9 Meters Biopharma (NASDAQ:NMTR) stock moved upwards by 22.8% to $0.25 during Tuesday's pre-market session. The company's market cap stands at $65.8 million.

Via Benzinga

Short Interest Sector Focus: Healthcare Sector ↗

September 26, 2022

As of the close of business on Friday, 9/23, we captured the Top 10 Highest Short Interest % stocks within the Healthcare Sector. The average short interest for stocks within the Healthcare sector...

Via Benzinga

7 Unknown Biotech Stocks That Could Rocket in 2023 ↗

September 23, 2022

Unknown biotech stocks that are poised for a big rally in 2023. Emerging biotech companies with a promising clinical pipeline.

Via InvestorPlace

Short Interest Sector Focus: Healthcare Sector ↗

August 30, 2022

As of the close of business on Monday, 8/29, we captured the Top 10 Highest Short Interest % stocks within the Healthcare Sector. The average short interest for stocks within the Healthcare sector...

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.